TCF7L2 and gastric cancer: A recent investigation found that TCF7L2 exhibits high expression levels in gastric cancer (GC) and is an independent risk factor for bad prognosis in GC patients, with evidence suggesting that it contributes to both anoikis resistance and the metastatic cascade (10).